ORKA Q4 2018 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$5,000

Operating Income

-$2M

Net Income

-$1M

EPS (Diluted)

$-23.10

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$7M

Total Liabilities

$793,000

Stockholders' Equity

$6M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5,000	-$6,000	+16.7%
Operating Income	-$2M	-$4M	+64.5%
Net Income	-$1M	-$4M	+64.5%